Related Experiment Video
Updated: Jun 12, 2026

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092
Published on: October 2, 2017
Sterol biosynthesis and sterol uptake in the fungal pathogen Pneumocystis carinii
Tiffany M Joffrion1, Melanie T Cushion
1Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA. joffritm@mail.uc.edu
Abstract:
Members of the fungal genus Pneumocystis colonize healthy mammalian hosts without causing apparent disease, but colonization in immunocompromised hosts may result in a potentially fatal pneumonia known as Pneumocystis pneumonia. Although Pneumocystis are fungi, this genus has characteristics that make it atypical among other fungi. Pneumocystis do not appear to synthesize the major fungal sterol, ergosterol, and biochemical analyses have shown that they utilize cholesterol rather than ergosterol as the bulk sterol. Pneumocystis carinii appears to scavenge exogenous sterols, including cholesterol, from its mammalian host. As a result, it has long been held that their ability to scavenge cholesterol from their hosts, and their inability to undergo sterol biosynthesis, makes them resistant to antifungal drugs that target ergosterol or ergosterol biosynthesis. However, genome scans and in vitro assays indicate the presence of sterol biosynthetic genes within the P. carinii genome, and targeted inhibition of these enzymes resulted in reduced viability of P. carinii, suggesting that these enzymes are functional within the organism. Heterologous expression of P. carinii sterol genes, along with biochemical analyses of the lipid content of P. carinii cellular membranes, have provided an insight into sterol biosynthesis and the sterol-scavenging mechanisms used by these fungi.
Insights
Pneumocystis fungi, often causing pneumonia in immunocompromised individuals, possess unique sterol biosynthesis pathways. Research reveals these fungi utilize cholesterol and have functional genes for sterol synthesis, impacting antifungal drug resistance.
Area of Science:
- Mycology
- Medical Mycology
- Fungal Pathogenesis
Background:
- Pneumocystis species are fungi that colonize mammals, causing Pneumocystis pneumonia in immunocompromised hosts.
- These fungi are atypical, utilizing cholesterol instead of ergosterol and scavenging sterols from hosts.
- This sterol utilization has historically suggested resistance to ergosterol-targeting antifungal drugs.
Purpose of the Study:
- To investigate the sterol biosynthesis pathways in Pneumocystis species.
- To understand the mechanisms of sterol scavenging and their implications for antifungal drug resistance.
- To determine the functionality of sterol biosynthetic genes in Pneumocystis carinii.
Main Methods:
- Genome scans to identify sterol biosynthetic genes in Pneumocystis carinii.
- In vitro assays to assess the functionality of these genes.
- Heterologous expression of Pneumocystis carinii sterol genes.
- Biochemical analyses of lipid content in Pneumocystis carinii cellular membranes.
Main Results:
- Genome scans and in vitro assays confirmed the presence and functionality of sterol biosynthetic genes in Pneumocystis carinii.
- Targeted inhibition of these enzymes led to reduced viability of Pneumocystis carinii.
- Biochemical analyses provided insights into both sterol biosynthesis and scavenging mechanisms.
Conclusions:
- Pneumocystis carinii possesses functional sterol biosynthesis pathways, contrary to previous assumptions.
- These findings challenge the notion that Pneumocystis are inherently resistant to all antifungal drugs.
- Understanding these pathways is crucial for developing new therapeutic strategies against Pneumocystis pneumonia.
Related Concept Videos
Biosynthesis of Lipids
Biosynthesis in Bacteria
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pneumonia II: Pathophysiology
Amino Acid Biosynthetic Pathways
Biosynthesis of Polysaccharides

